Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Dec 15;12(13):5083-7.
doi: 10.1002/j.1460-2075.1993.tb06202.x.

The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max

Affiliations

The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max

B Amati et al. EMBO J. .

Abstract

The c-Myc protein (Myc) is involved in cellular transformation and mitogenesis, but is also a potent inducer of programmed cell death, or apoptosis. Whether these apparently opposite functions are mediated through common or distinct molecular mechanisms remains unclear. Myc and its partner protein, Max, dimerize and bind DNA in vitro and in vivo through basic/helix-loop-helix/leucine zipper motifs (bHLH-LZ). By using complementary leucine zipper mutants (termed MycEG and MaxEG), which dimerize efficiently with each other but not with their wild-type partners, we demonstrate that both cell cycle progression and apoptosis in nontransformed rodent fibroblasts are induced by Myc-Max dimers. MycEG or MaxEG alone are inactive, but co-expression restores ability to prevent withdrawal from the cell cycle and to induce cell death upon removal of growth factors. Thus, Myc can control two alternative cell fates through dimerization with a single partner, Max.

PubMed Disclaimer

References

    1. Science. 1991 Oct 25;254(5031):539-44 - PubMed
    1. Oncogene. 1993 Feb;8(2):379-86 - PubMed
    1. Genes Dev. 1992 Jan;6(1):81-92 - PubMed
    1. Semin Cancer Biol. 1990 Feb;1(1):69-80 - PubMed
    1. Genes Dev. 1992 Feb;6(2):166-76 - PubMed

Substances